Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.3850
-0.0100 (-2.53%)
Jul 21, 2026, 3:29 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 29.94 million as of July 21, 2026. Its market cap has decreased by -14.53% in one year.
Market Cap
29.94M
Enterprise Value
28.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 29.94M, a decrease of -66.40%. That is a compound annual growth rate of -18.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 31.83M | -22.94% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 38.72M |
| Sona Nanotech | 36.03M |
| Resverlogix | 34.38M |
| Telescope Innovations | 33.94M |
| Medicenna Therapeutics | 32.31M |
| Thiogenesis Therapeutics | 29.55M |
| Quantum BioPharma | 28.79M |
| Lobe Sciences | 28.41M |